Press Releases Newbury Pharmaceuticals AB

Equities

NEWBRY

SE0015244884

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 14/06/2024 BST			5-day change	1st Jan Change
3.22 ^SEK	+0.62%		0.00%	+4.89%

04-10	Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	CI
02-22	Newbury Pharmaceuticals Secures SEK9 Million Sales Order	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Newbury Pharmaceuticals Q2 - A bump in the road	04-11	AQ
Newbury Pharmaceuticals interim report September 2023 – February 2024	04-10	AQ
Newbury Pharmaceuticals carries out a directed share issue of approximately SEK 19 million	03-04	AQ
Newbury Pharmaceuticals receives international sales order valued at 8.8 million SEK	02-22	AQ
Nintedanib Newbury approved by the Swedish Health Authorities	01-17	AQ
Newbury Pharmaceuticals Q1 Report - Ramp-up in sales	01-11	AQ
ANNUAL GENERAL MEETING OF SHAREHOLDERS IN NEWBURY PHARMACEUTICALS AB	01-10	AQ
Newbury Pharmaceuticals interim report September 2023 – November 2023	01-10	AQ
Newbury Pharmaceuticals publishes its annual report for 2022/2023	12-13	AQ
Kallelse till årsstämma i Newbury Pharmaceuticals AB	12-08	AQ
Newbury Pharmaceuticals is strengthening its portfolio with Melatonin Extended Release 2 mg	20/10/23	AQ
Newbury Pharmaceuticals Q4 Report - Bolstered business	12/10/23	AQ
Newbury Pharmaceuticals year-end report September 2022 – August 2023	11/10/23	AQ
Newbury Pharmaceuticals has entered into a partnership granting access to 6 registered products.	06/10/23	AQ
Newbury Pharmaceuticals is strengthening its portfolio with Levodopa/Benserazide	22/09/23	AQ
Newbury Pharmaceuticals AB has successfully signed a 15 MSEK loan agreement	18/09/23	AQ
Newbury gains access to the Nordic hospital market with a new strategic partnership for prescription medicine	23/08/23	AQ
Desmopressin Newbury approved by the Swedish Health Authorities	19/07/23	AQ
Newbury Pharmaceuticals sets financial goals for 2024 and 2028	16/06/23	AQ
Newbury Pharmaceuticals Q3 - Sales Ramp-up	14/06/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Newbury Pharmaceuticals AB

Equities

NEWBRY

SE0015244884

Press Releases

Filters